Barclays
COCH icon

Barclays’s Envoy Medical COCH Stock Holding History

Barclays’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196 Buy
+248
New +$168 ﹤0.01% 5112
2025
Q4 		– Sell
-203
Closed -$157 – 5309
2025
Q3 		$157 Buy
+203
New +$275 ﹤0.01% 5253

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Barclays's COCH Position: Q2 2026 in Review

Barclays opened a new position in Envoy Medical (COCH) in Q2 2026: 248 shares worth $196. The stake represents ﹤0.01% of the portfolio and ranks #5112 among its holdings. This is a return to the name: Barclays previously reported a position in COCH as recently as Q3 2025.

Barclays first reported a position in COCH in Q3 2025 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Barclays held 248 shares of Envoy Medical worth $196 as of Q2 2026.
  • Envoy Medical was a new Barclays position in Q2 2026.
  • Envoy Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5112 holding.
  • Barclays first reported a position in Envoy Medical in Q3 2025 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.